Comparison of the adverse events to interferon therapy in patients with chronic hepatitis C: standard interferon versus pegylated interferon
| Autor: | Akihisa Tanaka, Hiroshi Kamitsukasa, Michiyasu Yagura, Masanobu Iri |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Hepatology business.industry Ribavirin medicine.disease Gastroenterology chemistry.chemical_compound chemistry Pegylated interferon Interferon Internal medicine Immunology medicine Itching Platelet Hemoglobin medicine.symptom business Adverse effect Stomatitis medicine.drug |
| Zdroj: | Kanzo. 49:275-278 |
| ISSN: | 1881-3593 0451-4203 |
| DOI: | 10.2957/kanzo.49.275 |
| Popis: | We compared the adverse events among the same patients with chronic hepatitis C who were treated with standard interferon (IFN) with no response and again treated with pegylated interferon (PEG-IFN) combined with or without ribavirin (RIB), based on a questionnaire and blood count analysis. Patients were divided into four groups; standard IFN group, standard IFN+RIB group, PEG-IFN group, and PEG-IFN+RIB group. As a result, allergic reactions, such as itching, stomatitis, sneezing were much less seen in the standard IFN group, compared to PEG-IFN group. On the other hand, flu-like symptoms were more seen in the former than the latter. Hemoglobin and neutrophilic leukocyte counts significantly decreased until 16 weeks after starting the therapy in the groups with RIB than the groups without it. Platelet level significantly decreased at 2 weeks in the standard IFN+RIB group compared with PEG-IFN+RIB. As a whole, patients were satisfied with PEG-IFN therapy in view of visiting a doctor only once a week and its physical and mental easiness. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|